rag & bone Looks to the Future with Appointment of Stefanie Strack as Chief Executive Officer
8.8.2018 19:00:00 EEST | Business Wire | Press release
rag & bone announces today that Stefanie Strack has been named as its Chief Executive Officer.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180808005432/en/
rag & bone Announces Stefanie Strack As CEO (Photo: Business Wire)
Stefanie Strack’s appointment will become effective September 10th, 2018, at which time she will also be appointed to the rag & bone Board of Directors. Marcus Wainwright, the current CEO will assume a new title as Founder & Chief Brand Officer.
“I am beyond thrilled that Stefanie will be joining the company and I see her as a true partner. Stefanie brings us a wealth of experience in key strategic areas and personifies the rag & bone woman. Her coming on board allows me to focus on what I love, which is designing great product and continuing to build the rag & bone brand. Rag & bone has always challenged the status quo, always trying new ways of doing things. I know that Stefanie will continue that tradition of challenge and innovation leading us to an awesome future as a brand with a purpose and a singular focus on the customer.”
Marcus Wainwright, rag & bone Founder & Chief Brand Officer
Strack brings fresh perspective, energy, and strong leadership to rag & bone where she will focus on digital transformation and deepening the consumer connection globally across wholesale and direct-to-consumer. As an advocate for a more elevated, connected consumer experience, she will challenge the traditional product cycle and ignite the brand to become more personalized and responsive. Strack’s leadership style is uniquely suited to cultivate an inclusive and purpose-driven brand, which remains true to rag & bone’s focus on originality, quality and authenticity.
“As a professional, I have been inspired by rag & bone for years, and as a customer the brand has held a unique place in my heart. Authenticity is the essence of rag & bone, and I see that reflected throughout the rag & bone team. I am excited to be a part of this incredible culture, one that has purpose, passion and inspiration. We will create a brilliant future for those inside our company and those we serve.”
Stefanie Strack, rag & bone Chief Executive Officer
Strack has spent the last 14 years at Nike Inc., in a variety of operational and business roles, and has been an integral part of the Nike’s Corporate Leadership Team. Most recently, she held the position of Vice President/General Manager of Nike Express Lane, leading a global effort to meet evolving consumer needs with improved speed to market. Strack’s vision led to the development of a new division within Nike tasked with transforming all key direct-to-consumer functions: consumer sensing, data and analytics, design, supply chain and manufacturing. As noted in Nike’s earnings for the fourth quarter of fiscal 2018, Express Lane has created substantial impact and is now the fastest-growing product engine, serving as a key focal point of Nike’s speed initiative.
Prior to leading Nike Express Lane, Strack served as the General Manager of Nike Skateboarding. In that role, she focused on harnessing the passion of young millennials while bringing digital innovations to both the direct and wholesale marketplace. Strack now looks forward to bringing these rich insights and her multi-functional expertise home to rag & bone.
Through her culture-first, inclusive approach, Strack has become an innovative thought leader in the footwear and apparel industry and her extensive experience in leading, innovating and scaling visionary initiatives, will guide the evolution of rag & bone.
Her arrival comes as rag & bone prepares to accelerate its direct-to-consumer efforts. Having already become known as an industry disruptor, this appointment signals the next evolution in a brand consistently recognized for its uniquely individualistic and innovative approach.
About rag & bone:
Since its origins in New York in 2002, rag & bone has established itself as a critical and commercial success in the international fashion world. Combining English heritage with directional design, the brand has become synonymous with innately wearable clothing that has an edgy yet understated New York aesthetic.
rag & bone offers a full range of men’s and women’s ready to wear, denim, accessories and footwear collections. rag & bone operates 42 stores worldwide and also available in boutiques and department stores in over 53 countries. www.rag-bone.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180808005432/en/
Contact information
For all enquiries:
rag & bone
Miles
Freeland, 646-776-8993
Miles.freeland@rag-bone.com
or
Whitney
Saffel, 646-776-8911
Whitney.Saffel@rag-bone.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Fortegra Completes Acquisition by DB Insurance29.5.2026 23:30:00 EEST | Press release
The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 23:01:00 EEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 16:00:00 EEST | Press release
NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 15:00:00 EEST | Press release
Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 14:00:00 EEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
